Aleniglipron is an orally active glucagon-like peptide-1 receptor (GLP-1R) agonist, with an EC50 value of less than 0.1 nM in HDB cell lines in cAMP stimulation assays. Aleniglipron selectively activates the Galphas-cAMP signaling pathway of GLP-1R without beta-arrestin recruitment. Aleniglipron induces insulin release, promotes glucose clearance, reduces food intake and decreases body weight. Aleniglipron is applicable to research related to type 2 diabetes and obesity[1][2].
Molecular Weight:
915.99
Purity:
99.88
CAS Number:
[2685823-26-9]
Formula:
C49H55FN9O6P
Target:
GLP Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted